Two out of three patients with peripheral artery disease or peripheral neuropathy have no symptoms. When you refer out or do not test, they leave undiagnosed, and the missing documentation now costs your practice. Here is what changed in 2026, and what to look for in an in-office test.
Two-thirds of patients with peripheral artery disease or peripheral neuropathy are asymptomatic. Without in-office testing, the window to intervene before amputation, stroke, or readmission closes silently, and the documentation gap has become a financial liability.
OIG findings released in late 2025 indicate roughly 44% of submitted claims lack adequate supporting documentation. AI-driven prospective review is replacing the old "submit-then-audit-later" model.
CMS reduced skin-substitute payment from roughly $1,000/cm² to $127/cm² in 2025, and ABI documentation is now a precondition for many dressing claims. Quantitative, audit-defensible ABI is no longer optional.
ACOs and Medicare Advantage plans pay for prevented complications. A practice with no PAD or neuropathy testing is invisible in risk-adjustment data and forfeits chronic-disease revenue.
Five reasons Smart-ABI is the defensible choice for early detection and durable practice revenue.
Detect PAD and autonomic neuropathy in one seven-minute test. The sudomotor module is unique to the Smart-LEDA+ platform.
True cuff-based, four-limb measurement with VPR waveforms and Doppler-correlated accuracy: the methodology CMS technical requirements are built around.
Built to qualify for CPT 93922, 93923, and 95923 from the first test, with reports formatted for audit defensibility.
Reps install the device on-site and train your medical assistants on the Smart-ABI Process, so an MA can run the test before the physician enters the room. Most competitors ship the box.
Color-coded ABI/VPR reports with patient trending, signed by qualified specialists and EMR-ready: built to hold up to RAC audits and AI-driven claims review.
Book a virtual or on-site demo and walk through the five-minute test with a Smart-ABI specialist.
Schedule a DemoWhen the MA-driven Smart-ABI Process is followed, a single device can generate substantial CPT-code revenue with comparatively trivial incremental staff time. And the clinical math is even simpler: one avoided amputation alone can repay the capital investment several times over.
*Illustrative ROI modeling from Hyperion sales materials; actual reimbursement varies by payer, region, patient volume, and documentation. Not a guarantee of revenue.
Book a demo and a Smart-ABI specialist will walk your team through patient selection, the MA-operated workflow, reimbursement, and the report your EMR receives.